prednisone has been researched along with cyclin d1 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, E; Caracciolo, F; Di Renzo, N; Fazzi, R; Federico, M; Galimberti, S; Guerrini, F; Marasca, R; Morabito, F; Oliva, E; Papineschi, F; Petrini, M; Torelli, G | 1 |
| Bai, YQ; Chen, Y; Feng, J; Ji, H; Li, C; Li, FY; Li, GD; Tang, Y; Wang, LJ; Xia, T; Yang, MZ; Yixi, JC; Zhang, P; Zou, ZK | 1 |
| Kanno, M; Maeda, Y; Masaki, Y; Miura, K; Mori, H; Motomura, S; Takai, K; Takasaki, H; Takeuchi, J; Takizawa, J; Terasaki, Y; Tomita, N; Tsujimura, H; Yoshida, T | 1 |
| Chen, D; Colgan, JP; Hanson, CA; Ketterling, RP; Viswanatha, DS; Zent, CS | 1 |
| Deng, LJ; Lin, NJ; Liu, WP; Ping, LY; Song, YQ; Tu, MF; Wang, XP; Xie, Y; Ying, ZT; Zhang, C; Zheng, W; Zhu, J | 1 |
| Bhagat, G; Dybkaer, K; Farnen, JP; Han van Krieken, J; Hsi, ED; Medeiros, LJ; Montes-Moreno, S; Møller, MB; O'Malley, DP; Ok, CY; Orazi, A; Piris, MA; Ponzoni, M; Richards, KL; Tzankov, A; Visco, C; Winter, JN; Xu-Monette, ZY; Young, KH; Zu, Y | 1 |
| Bertoni, F; Bhagat, G; Chen, J; Chiu, A; Choi, WW; Dybkær, K; Farnen, JP; Ferreri, AJ; Hsi, ED; Huh, J; Li, L; Manyam, GC; Medeiros, LJ; Montes-Moreno, S; Møller, MB; Ok, CY; Orazi, A; Piris, MA; Ponzoni, M; Richards, KL; Tzankov, A; van Krieken, JH; Visco, C; Winter, JN; Xu-Monette, ZY; Young, KH; Zhao, X; Zu, Y | 1 |
| Feng, J; Peng, W; Wu, J | 1 |
| Bai, W; Liang, X; Sun, R; Wang, J | 1 |
| Csóka, M; Csordás, K; Eipel, O; Erdélyi, D; Hegyi, M; Kovács, G; Luczay, A; Németh, K; Török, D | 1 |
| Kahana, A; Kim, TN; Zhao, PY | 1 |
| Chen, G; Chen, X; Duan, Y; Fan, J; He, B; Huang, H; Liu, W; Pan, J; Shen, H; Wu, D; Zeng, Z; Zhu, M | 1 |
12 other study(ies) available for prednisone and cyclin d1
| Article | Year |
|---|---|
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Genes, bcl-2; Humans; Immunoglobulin Heavy Chains; Leukapheresis; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Predictive Value of Tests; Prednisone; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
[Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
Topics: Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD5 Antigens; CD79 Antigens; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 2007 |
Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Clinical Trials as Topic; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Japan; Karyotyping; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine | 2011 |
A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclin D1; Cyclophosphamide; Doxorubicin; Drug Substitution; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Remission Induction; Translocation, Genetic; Treatment Failure; Vincristine; Withholding Treatment | 2011 |
The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Vincristine | 2012 |
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Murine-Derived; Cyclin D1; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Mice; Middle Aged; Prednisone; Prevalence; Prognosis; Rituximab; Vincristine; Young Adult | 2014 |
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclin D1; Cyclophosphamide; Doxorubicin; Female; Gene Expression; Genes, bcl-2; Genes, myc; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NF-kappa B; Phosphorylation; Prednisone; Prognosis; Proto-Oncogene Proteins c-akt; Rituximab; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Tumor Suppressor Protein p53; Vincristine | 2014 |
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclophosphamide; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Recurrence; Rituximab; RNA, Long Noncoding; Signal Transduction; Survival Analysis; Vincristine | 2017 |
[Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclin D1; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Gene Rearrangement; Germinal Center; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Vincristine | 2015 |
Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.
Topics: Adolescent; Child; Child, Preschool; Cyclin D1; Disease-Free Survival; Glucocorticoids; Humans; Infant; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Receptors, Glucocorticoid; Steroids; Survival Rate | 2016 |
Blurred Vision and Wrinkled Retinas in an Elderly Man.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choroid Diseases; Cyclin D1; Cyclophosphamide; Doxorubicin; Flow Cytometry; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Orbital Neoplasms; Pleural Effusion; Positron-Emission Tomography; Prednisone; Retinal Diseases; Rituximab; Tomography, X-Ray Computed; Vincristine; Vision Disorders; Visual Acuity | 2019 |
Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclin D1; Cyclophosphamide; Doxorubicin; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Lenalidomide; Lymphoma, Mantle-Cell; Male; Neoplasm Proteins; Positron Emission Tomography Computed Tomography; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Remission Induction; Rituximab; Vincristine | 2021 |